43 related articles for article (PubMed ID: 8127144)
1. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes.
Fernández-Sevilla LM; Valencia J; Ortiz-Sánchez P; Fraile-Ramos A; Zuluaga P; Jiménez E; Sacedón R; Martínez-Sánchez MV; Jazbec J; Debeljak M; Fedders B; Stanulla M; Schewe D; Cario G; Minguela A; Ramírez M; Varas A; Vicente Á
Blood; 2022 Jun; 139(22):3303-3313. PubMed ID: 35313334
[TBL] [Abstract][Full Text] [Related]
2. The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia.
Farrokhi A; Atre T; Rever J; Fidanza M; Duey W; Salitra S; Myung J; Guo M; Jo S; Uzozie A; Baharvand F; Rolf N; Auer F; Hauer J; Grupp SA; Eydoux P; Lange PF; Seif AE; Maxwell CA; Reid GSD
Leukemia; 2024 May; 38(5):969-980. PubMed ID: 38519798
[TBL] [Abstract][Full Text] [Related]
3. Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish.
Rothschild SC; Lai G; Tombes RM; Clements WK
PLoS Genet; 2023 Dec; 19(12):e1011102. PubMed ID: 38117861
[TBL] [Abstract][Full Text] [Related]
4. Flow Sorting, Whole Genome Amplification and Next-Generation Sequencing as Combined Tools to Study Heterogeneous Acute Lymphoblastic Leukemia.
Fardoos R; Christensen C; Øbro NF; Overgaard UM; Als-Nielsen B; Madsen HO; Marquart HV
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958202
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.
Moses BS; Slone WL; Thomas P; Evans R; Piktel D; Angel PM; Walsh CM; Cantrell PS; Rellick SL; Martin KH; Simpkins JW; Gibson LF
Exp Hematol; 2016 Jan; 44(1):50-9.e1-2. PubMed ID: 26407636
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia.
Barsan V; Xia Y; Klein D; Gonzalez-Pena V; Youssef S; Inaba Y; Mahmud O; Natarajan S; Agarwal V; Pang Y; Autry R; Pui CH; Inaba H; Evans W; Gawad C
Sci Adv; 2022 Apr; 8(16):eabj1360. PubMed ID: 35442732
[TBL] [Abstract][Full Text] [Related]
7. Defining the Basal and Immunomodulatory Mediator-Induced Phosphoprotein Signature in Pediatric B Cell Acute Lymphoblastic Leukemia (B-ALL) Diagnostic Samples.
Khanolkar A; Liu G; Simpson Schneider BM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762241
[TBL] [Abstract][Full Text] [Related]
8. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia.
Scholten C; Födinger M; Mitterbauer M; Laczika K; Mitterbauer G; Haas OA; Knöbl P; Schwarzinger I; Thalhammer R; Purtscher B
Ann Hematol; 1995 Oct; 71(4):155-60. PubMed ID: 7578520
[TBL] [Abstract][Full Text] [Related]
10. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.
van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936
[TBL] [Abstract][Full Text] [Related]
11. Isolated bone relapse during hematologic remission in childhood acute lymphoblastic leukemia: report of a metatarsal relapse and review of the literature.
Murray JC; Gmoser DJ; Barnes DA; Oshman D; Hawkins HK; Gresik MV; Dreyer ZE
Med Pediatr Oncol; 1994; 23(2):153-7. PubMed ID: 8202041
[TBL] [Abstract][Full Text] [Related]
12. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
Kitchingman GR
Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
[TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
[TBL] [Abstract][Full Text] [Related]
14. Pattern of T-cell receptor delta gene rearrangement by Southern blotting and polymerase chain reaction technique in Hong Kong Chinese patients with non-T-cell hematological malignancies.
Chan DW; Liang R; Kwong YL
Hematol Oncol; 1996 Jun; 14(2):57-66. PubMed ID: 8876635
[TBL] [Abstract][Full Text] [Related]
15. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
